| 1 | PARN, TOE1 |
| PARN and TOE1 Constitute a 3' End Maturation Module for Nuclear Non-coding RNAs. | |
| Son A, Park JE, Kim VN. | |
| Cell Rep 23(3):888-898. doi: 10.1016/j.celrep.2018.03.089. 2018 | |
| 2 | PCH7, TOE1 |
| Biallelic mutations in the 3' exonuclease TOE1 cause pontocerebellar hypoplasia and uncover a role in snRNA processing. | |
| Lardelli RM, Schaffer AE, Eggens VR, Zaki MS, Grainger S, Sathe S, Van Nostrand EL, Schlachetzki Z, Rosti B, Akizu N, Scott E, Silhavy JL, Heckman LD, Rosti RO, Dikoglu E, Gregor A, Guemez-Gamboa A, Musaev D, Mande R, Widjaja A, Shaw TL, Markmiller S, Marin-Valencia I, Davies JH, de Meirleir L, Kayserili H, Altunoglu U, Freckmann ML, Warwick L, Chitayat D, Blaser S, Çağlayan AO, Bilguvar K, Per H, Fagerberg C, Christesen HT, Kibaek M, Aldinger KA, Manchester D, Matsumoto N, Muramatsu K, Saitsu H, Shiina M, Ogata K, Foulds N, Dobyns WB, Chi NC, Traver D, Spaccini L, Bova SM, Gabriel SB, Gunel M, Valente EM, Nassogne MC, Bennett EJ, Yeo GW, Baas F, Lykke-Andersen J, Gleeson JG. | |
| Nat Genet 49(3):457-464. doi: 10.1038/ng.3762. Epub 2017 Jan 16. 2017 | |
| 3 | EGR1, TOE1 |
| TOE1 is an inhibitor of HIV-1 replication with cell-penetrating capability. | |
| Sperandio S, Barat C, Cabrita MA, Gargaun A, Berezovski MV, Tremblay MJ, de Belle I. | |
| Proc Natl Acad Sci U S A 112(26):E3392-401. doi: 10.1073/pnas.1500857112. Epub 2015 Jun 8. 2015 | |
| 4 | TOE1, TP53 |
| TOE1 interacts with p53 to modulate its transactivation potential. | |
| Sperandio S, Tardito S, Surzycki A, Latterich M, de Belle I. | |
| FEBS Lett 583(13):2165-70. Epub 2009 Jun 7. 2009 | |
| 5 | TOE1 |
| In vivo cloning and characterization of a new growth suppressor protein TOE1 as a direct target gene of Egr1. | |
| De Belle I, Wu JX, Sperandio S, Mercola D, Adamson ED. | |
| J Biol Chem 278(16):14306-12. Epub 2003 Jan 31. 2003 | |